GESTALT CLINICAL TRIAL for PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMAS (GBMs) | ENROLLING NOW
Patient Resources
Why participate?
Patients in the GESTALT Clinical Trial benefit from immediate radiation treatment at the completion of their brain tumor removal surgery, plus the Stupp protocol standard of care. Studies show that earlier radiation treatment may be more effective than later treatment.[1,2]
The GESTALT Clinical Team will closely monitor your care. And you’ll be making a valuable contribution to future patients, helping to provide more information about how starting radiation immediately, instead of waiting, can improve outcomes.
REFERENCES
-
Do V, Gebski V, Barton MB. The effect of waiting for radiotherapy for grade III/IV gliomas. Radiother Oncol. 2000;57(2):131-136.
-
Irwin C, Hunn M, Purdie G, Hamilton D. Delay in radiotherapy shortens survival in patients with high-grade glioma. J Neurooncol. 2007;85(3):339-343.